GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carmat (XPAR:ALCAR) » Definitions » Investments And Advances

Carmat (XPAR:ALCAR) Investments And Advances : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Carmat Investments And Advances?

Carmat's Investments And Advances for the quarter that ended in Dec. 2023 was €0.00 Mil.


Carmat Investments And Advances Historical Data

The historical data trend for Carmat's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carmat Investments And Advances Chart

Carmat Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Carmat Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Carmat Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Carmat (XPAR:ALCAR) Business Description

Traded in Other Exchanges
Address
36, avenue de l’Europe, Immeuble l’Etendard Energy III, Velizy Villacoublay, FRA, 78140
Carmat is a France-based company engaged in the development and production of heart prosthesis. It engages in the development of implantable orthotopic and biocompatible artificial heart organs for the treatment of heart failure patients. The company also develops the product's power supply system and its control and remote diagnosis systems.

Carmat (XPAR:ALCAR) Headlines

No Headlines